corresponding to the different lipid classes were identified via the authentic standards after 143 primuline staining, scraped off and subsequently extracted and esterified for analysing FA 144 profiles with internal standards.
145
A one-step lipid extraction, methylation and trans-esterification method with subsequent 146 gas chromatography (GC) [22] was used to determine the total FA content and lipid class FA 147 compositions of the various ATs and liver tissues, with L-phosphadidylcholin-C17:0 (0.8 mg/ml) 148 as an internal standard. 149 Fatty acid methyl esters (FAMEs) were separated on a Varian CP 3800 gas 150 chromatograph (GC, Varian, Darmstadt, Germany) equipped with a 30 m Omegawax TM 320 151 capillary column (0.32-mm ID, 0.2 µm df) (Supelco, Bellefonte, PA, USA). The GC oven 152 temperature was set at 200 °C, and helium was used as a carrier gas with a flow rate of 1 ml/min. 153 Chromatographic peaks were integrated by the Star 5.0 software (Varian) using the internal 154 standard as the reference peak. FAMEs were used to identify and evaluate FAs assuming a direct 155 relationship between peak area and FAME weight. Total FA was expressed as µmol/g tissue or 156 µmol/ml, and FA composition was expressed as percent of total FA content. Blank values were 10 161 Desaturase and elongase activity indices 162 Desaturase and elongase activity indices were calculated using the product/precursor ratio 163 of the percentages of individual FAs according to the following notation: C16:1n-7/C16:0 = Δ9-164 desaturase (SCD16), C18:1n-9/C18:0 = Δ9-desaturase (SCD18), C18:3n-6/C18:2n-6 = Δ6-165 desaturase (D6D), and C20:4n-6/C20:3n-6 = Δ5-desaturase (D5D) and C18:0/C16:0 = elongase 166 (Elo).
168
Statistical analysis 169 Statistical analyses were performed using a statistical software program (Statistica, 170 StatSoft GmbH, Hamburg, Germany). Data were tested for normality by the Shapiro-Wilk test. 171 Levene's test was used to assess equality of variance. A non-parametric Mann-Whitney U-test 172 was applied to determine differences in the lipid FA composition and FA ratios between horses 173 and ponies. The Kruskal-Wallis ANOVA was used to compare different locations for FA 174 distribution and FA ratios. A two-tailed Dunn's test correcting for multiple comparisons was 175 done as a post hoc test. Differences were considered significant at P values lower than 0.05. Data 176 are presented as medians with 25 th and 75 th percentiles. 
Results

180
FA composition of adipose tissue 181 The total lipid FA concentrations of RPN-, MSC-and SCfat were similar between horses 182 and ponies, but higher FA levels were found in the liver tissue of ponies than in those of horses 183 (Table 1) . Saturated fatty acids (SFAs) and n-9 monounsaturated fatty acids (MUFAs) were the 184 most abundant FA groups in the RPN-, the MSC-and SCfat depots ( ponies. There were no significant differences in the percent composition of the SFA, MUFA and 186 iso-branched-chain FA (iso-BCFA) fractions between horses and ponies. Horses had a 187 significantly higher amount of n-6 PUFAs (P < 0.01) and a trend for lower n-3 PUFAs than 188 ponies. In addition to SFAs, PUFAs of the n-6 FA family were the most dominant lipid FA in the 215 liver ( Table 2 ). The hepatic n-3 PUFA content was not different between ponies and horses, but 216 the percentage of the hepatic n-6 PUFA fraction was significantly higher in horses than in 217 ponies. The n-6/n-3 ratios calculated for all tissues and plasma in horses were significantly lower 218 than those in ponies. Except for the total hepatic n-11 MUFA fraction in ponies, MUFA contents 219 were lower in the liver than in AT depots for both horses and ponies. The total n-11 MUFA 220 concentration in the liver of ponies was 5-fold higher than the corresponding MUFA content in 221 horses.
222
Ponies contained a 2-fold higher proportion of n-11 MUFAs in the liver than in the 223 different ATs. Liver iso-BCFA content (10.0%) was 5-fold higher in ponies than in horses.
225
FA composition of plasma 226 In horses and ponies, SFAs and PUFAs of the n-6 FA family represented the majority of 227 plasma lipids (Table 2) .
229
Tissue comparison 230 A comparison of the different fat depots with liver tissue showed that horses and ponies 231 have inverted n-6/n-3 PUFA ratios and higher percentages of iso-BCFAs in the liver than in the 232 AT depots (Table 2) .
233
Δ9-desaturase activity indices determined from the 16:1n7/16:0 ratio and 18:1n9/18:0 234 ratio were significantly lower in the liver than in the ATs for both horses and ponies ( Fig 1A and 235 B). Increased Δ6-and Δ5-desaturase and elongase indices were found in the liver compared to 236 the AT depots in all animals ( Fig 1C-E) . In this context, horses had a significantly higher hepatic 237 Δ5-desaturase index than ponies ( Fig 1D) . Plasma FA lipid composition (Table 1b) In all animals, the majority of hepatic FAs accumulated in the polar PL fraction. Among 253 the neutral FA fractions, TAGs had the highest FA amount, followed by NEFAs and CEs
254
( Table 3 ). The absolute amounts of FAs in the PL fraction were significantly higher in ponies 255 than in horses (P = 0.004). In ponies, the FA levels in the hepatic NEFA fraction were 2-fold 256 higher (P = 0.03) and that of the CE fraction 3-fold higher (P = 0.004) than those in horses.
257
There were no significant differences in the FA levels of TAGs except for one pony that followed by SFAs, n-9 MUFAs, n-3 PUFAs together with iso-BCFAs and, at last, n-7 and n-11
274
MUFAs (Table 4 ). Compared to horses, ponies had significant higher n-9 MUFA and n-3 PUFA 20 275 levels but significant lower n-6 PUFA contents in the PL fraction, resulting in a lower n-6/n-3 276 ratio. No significant differences in SFA and iso-BCFA levels were found in the hepatic PL 277 fractions between horses and ponies. Similar to the PL fraction, n-6 PUFA levels and calculated 278 n-6/n-3 ratios in NEFAs, TAGs and CE were significantly higher in horses than in ponies. N-11
279
MUFAs and 280 iso-BCFAs were absent from the hepatic NEFA fraction of horses. In ponies, the hepatic CE 281 fraction had significantly higher n-3 PUFA levels but lower SFA amounts than that in horses.
282
Ponies had the highest iso-BCFA levels and the lowest n-9 PUFA contents in the hepatic CE 283 fraction. These FAs were completely absent from the CE fraction of the horse liver. [28,31,32]. To minimize dietary effects, feeding protocols were standardized in animals by 317 feeding them meadow hay for several weeks. In the present study, no significant differences in 25 318 the total FA content and FA lipid profile between the distinct AT locations were found in horses 319 and ponies (Table 1) .
320
Our results confirmed previous studies that highlighted n-3 PUFAs and, to a lesser extent, and CEs for both horses and ponies (Table 3) . Interestingly, SFA levels were quite similar 331 between ATs and liver, but significant differences were found in MUFA and essential n-6 PUFA 332 levels ( Furthermore, the majority of de novo synthesis of non-essential FAs may occur in the AT depots 335 and not in the liver, as has been recently described for equids [36] . Data from the present study, 336 showing significantly higher 16:1n-7/16:0 and 18:1n9/18:0 ratios in the AT depots than in liver 337 tissue, supports these findings by reflecting a higher AT Δ9-desaturase activity (Fig 1A and B) . 
353
Higher n-6 PUFA levels resulted in reduced n-3 PUFA levels, explaining the n-3/n-6 ratio being 354 inverted between liver and ATs (Table 2) . horses and ponies for liver tissue and some ATs (Fig 1A, B, D PUFAs in the diet to a n-3/n-6 PUFA ratio of 1:1 was evidenced to prevent excessive n-6 414 eicosanoid action and Toll-like receptor 4 (TLR4)-induced production of pro-inflammatory 415 cytokines via an effective blocking of corresponding signalling pathways by n-3 PUFA action.
416
This approach avoids metabolic disorders and is beneficial for health. Use of n-6 PUFA-30 417 dominated dietary ratios of 1:4 failed to result in these changes [61, 62] . However, it cannot be 418 excluded that the adaptation period to the same diet was too short to exclude any dietary 419 influences on PUFAs in the present study.
420
Another interesting finding of the current study was the high iso-BCFA content in the 421 liver of horses and ponies compared to that in the ATs ( TAG accumulation. This link was also confirmed in the current study. However, the highest iso-
445
BCFA contents were highlighted in the CE fraction of the pony liver, in contrast to a complete 446 lack of hepatic CE iso-BCFAs in horses. Clearly, there exists species-derived differences in iso-
447
BCFA metabolism that might be linked to cholesterol metabolism in equids. We further 448 speculate that different expression patterns of receptors and enzymes are involved in intracellular 449 degradation, turnover and transport of iso-BCFAs through the plasma membranes in ponies and 450 horses. Further research on the entire role and metabolism of iso-BCFAs in hepatic FA 451 metabolism is required. In that context, it seems appropriate to investigate the function of 452 different iso-BCFAs in context with metabolic dysregulation in horses and ponies.
453
Interestingly, horses rather than ponies lack some of the FA classes in different hepatic neutral TAG fraction (44.1% of total FA) as we did. However, data on the long chain FA were 457 missing, which is partly offset by data from the current study.
458
FA levels and lipid profiles were similar between liver and plasma, suggesting plasma as 459 a potential biomarker for liver lipid content and FA lipid composition [74] . These findings are 460 further supported by the close relationship of the FA elongase and desaturase indices in the liver 461 and plasma, which were both different from those in the ATs (Fig 1A-E) . The present results provide basic data on the FA profiles in different ATs, liver and 465 plasma in lean horses and ponies under standard conditions. The higher n-6/n-3 ratios in the ATs, 466 liver and plasma of horses in comparison to ponies and differences in the desaturase and 467 elongase indices may reflect breed-related differences in the acquisition (e.g., FA uptake and de 468 novo lipogenesis), removal (i.e., mitochondrial FA oxidation and FA mobilization) and turnover 469 of FA. In liver tissue, horses also had lower hepatic iso-BCFA levels than ponies. As iso-BCFAs 470 are linked to anti-inflammatory and insulin-synthesizing effects, these findings need further 471 elucidation.
472
